Shawn M. Guertin - 01 Apr 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Reporting relationship: EVP & Chief Financial Officer
Issuer ticker: CVS
Reported as of: 01 Apr 2023
Net transaction value: +$11,031,765
SEC form: 4
Accepted by SEC: 04 Apr 2023, 16:28:21 UTC
Prior SEC filing: 05 Apr 2022
Next SEC filing: 09 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Shawn M. Guertin

Key filing fact

Shawn M. Guertin filed Form 4 for CVS HEALTH Corp (CVS) on 04 Apr 2023.

Key facts

This page summarizes Shawn M. Guertin's Form 4 filing for CVS HEALTH Corp (CVS).
1 reported transaction and 3 derivative rows are listed below.
Accepted by SEC: 04 Apr 2023, 16:28.

Change

Previous filing in this sequence was filed on 05 Apr 2022.
Current net transaction value: +$11,031,765.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 9,260
Date: 01 Apr 2023
Ownership: Direct

CVS holding

Common Stock (Restricted)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 34,706
Date: 01 Apr 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CVS transaction Derivative

Stock Option

Award

Transaction value: $11,031,765
Shares: +148,456
Change %
Price: $74.31
Shares after: 148,456
Date: 01 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 148,456
Exercise price: $74.31
Footnotes: F2

CVS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 97,562
Date: 01 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 97,562
Exercise price: $1.00

CVS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 103,950
Date: 01 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 103,950
Exercise price: $101.09
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Option became exercisable in four equal installments, commencing 4/1/2023.

Footnote F2

Option becomes exercisable in four equal annual installments, commencing 4/1/2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .